Venture capital

India’s biotech sector is powering ahead, with 30 per cent annual growth over the past four years. But venture capitalists are still not tempted to invest.

IPOs are up in the year to date. But the value of these deals is down. Rather than cashing out, VCs are getting a ticket to stay on for a white-knuckle ride.

The US biotechnology industry has gone through more than three years of sustained IPO financings, but that news isn’t all rosy for the industry.

Russia’s economics minister, German Gref, has announced the name of the three companies selected to manage the funds of the Russian Venture Company, set up by the government to diversify the economy away from commodities and invest in high-tech projects.